Key result
The presence of right ventricular dysfunction determined by echocardiography or elevated natriuretic peptides was associated with increased short-term mortality in patients with pulmonary embolism without hemodynamic compromise.
Why the study?
Does the presence of right ventricular dysfunction predict short-term mortality in patients with pulmonary embolism without hemodynamic compromise?
Meta-Analysis (n=2,334)
Does the presence of right ventricular dysfunction predict short-term mortality in patients with pulmonary embolism without hemodynamic compromise?
Echocardiographic right ventricular dysfunction and elevated natriuretic peptides are associated with short-term mortality in normotensive pulmonary embolism, but their clinical utility for risk stratification is limited by poor likelihood ratios.
Answers are grounded in this paper and cite their sources.
May inform closer monitoring in higher-risk normotensive PE; confirms prognostic associations yet leaves open utility for guiding therapy.
INTRODUCTION: In pulmonary embolism (PE) without hemodynamic compromise, the prognostic value of right ventricular (RV) dysfunction as measured by echocardiography, computed tomography (CT) or biological (natriuretic peptides) markers has only been assessed in small studies. METHODS: Databases were searched using the combined medical subject headings for right ventricular dysfunction or right ventricular dilatation with the exploded term acute pulmonary embolism. This retrieved 8 echocardiographic marker based studies (n = 1249), three CT marker based studies (n = 503) and 7 natriuretic peptide based studies (n = 582). A meta-analysis of these data was performed with the primary endpoint of mortality within three months after pulmonary embolism, and a secondary endpoint of overall mortality and morbidity by pulmonary embolism. RESULTS: Patients with PE without hemodynamic compromise on admission and the presence of RV dysfunction determined by echocardiography and biological markers were associated with increased short-term mortality (odds ratio (OR) ECHO = 2.36; 95% confidence interval (CI): 1.3-43; OR BNP = 7.7; 95% CI: 2.9-20) while CT was not (ORCT = 1.54-95% CI: 0.7-3.4). However, corresponding pooled negative and positive likelihood ratios independent of death rates were unsatisfactory for clinical usefulness in risk stratification. CONCLUSIONS: The presence of echocardiographic RV dysfunction or elevated natriuretic peptides is associated with short-term mortality in patients with pulmonary embolism without hemodynamic compromise. In contrast, the prognostic value of RV dilation on CT has yet to be validated in this population. As indicated both by positive and negative likelihood ratios the current prognostic value in clinical practice remains very limited.
No takes yet. Share an insight, caveat, or question.
Coutance et al. (2011) conducted a meta-analysis in Pulmonary embolism without hemodynamic compromise (n=2,334). Right ventricular dysfunction (assessed by echocardiography) vs. Absence of right ventricular dysfunction was evaluated on All-cause mortality within 3 months (OR 2.36, 95% CI 1.3-4.3). The presence of right ventricular dysfunction determined by echocardiography or elevated natriuretic peptides was associated with increased short-term mortality in patients with pulmonary embolism without hemodynamic compromise.
Synapse has enriched 10 related papers. Consider them for comparative context: